Form 8-K - Current report:
SEC Accession No. 0001193125-17-183791
Filing Date
2017-05-25
Accepted
2017-05-25 16:36:57
Documents
1
Period of Report
2017-05-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d397561d8k.htm 8-K 12452
  Complete submission text file 0001193125-17-183791.txt   13643
Mailing Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE SUITE B7201 CAMBRIDGE MA 02139 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35409 | Film No.: 17870539
SIC: 2834 Pharmaceutical Preparations